Submitted by admin on Fri, 2025-04-25 13:24

Soliris

  • Brand name/Generic name: Soliris/eculizumab
  • How Administered at HOA: intravenous infusion
  • Duration of Treatment: thirty five minutes
  • Frequency of Treatment: once per week for the first 5 weeks and once every 2 weeks thereafter
  • Conditions this Medication Treats: anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome, myasthenia gravis
  • Link for more Information: https://solirisnmosd.com/
Main Image: